Isis E. Fernandez

2.7k total citations · 2 hit papers
30 papers, 1.5k citations indexed

About

Isis E. Fernandez is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Isis E. Fernandez has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Isis E. Fernandez's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Neonatal Respiratory Health Research (3 papers). Isis E. Fernandez is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Neonatal Respiratory Health Research (3 papers). Isis E. Fernandez collaborates with scholars based in Germany, United States and Cuba. Isis E. Fernandez's co-authors include Oliver Eickelberg, Iván O. Rosas, Gary M. Hunninghake, George R. Washko, Hiroto Hatabu, Frank C. Sciurba, Yuka Okajima, Mizuki Nishino, Tsuneo Yamashiro and Edwin K. Silverman and has published in prestigious journals such as New England Journal of Medicine, The EMBO Journal and PLoS ONE.

In The Last Decade

Isis E. Fernandez

28 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Impact of TGF-β on Lung Fibrosis: From Targeting to Biomarkers

2012 549 citations Isis E. Fernandez, Oliver Eickelberg Proceedings of the American Thoracic Society profile →
Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities

2011 384 citations George R. Washko, Gary M. Hunninghake et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Isis E. Fernandez

Since Specialization

Citations

This map shows the geographic impact of Isis E. Fernandez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isis E. Fernandez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isis E. Fernandez more than expected).

Fields of papers citing papers by Isis E. Fernandez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isis E. Fernandez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isis E. Fernandez. The network helps show where Isis E. Fernandez may publish in the future.

Co-authorship network of co-authors of Isis E. Fernandez

This figure shows the co-authorship network connecting the top 25 collaborators of Isis E. Fernandez. A scholar is included among the top collaborators of Isis E. Fernandez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isis E. Fernandez. Isis E. Fernandez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improved survival of patients with stage III small-cell lung cancer with primary resection: A SEER-based analysis 2024 ·Translational Oncology ·(unknown), (unknown), Fanli Kong, (unknown), Ruonan Liu, Zhengwu Sun, Xiaoyan Lan, Ali Önder Yildirim, Georgios T. Stathopoulos, Isis E. Fernandez, Andrea C. Schamberger	1
2	DNA sensing via the cGAS/STING pathway activates the immunoproteasome and adaptive T‐cell immunity 2023 ·The EMBO Journal ·Xinyuan Wang, Huabin Zhang, Yuqin Wang, (unknown), Kai Guo, (unknown), (unknown), Qianjiang Hu, (unknown), Ilona Kammerl, Mélanie Königshoff, Mareike Lehmann, Thomas Magg, Fabian Hauck, Isis E. Fernandez, Silke Meiners	34
3	Lung Epithelial CYP1 Activity Regulates Aryl Hydrocarbon Receptor Dependent Allergic Airway Inflammation 2022 ·Frontiers in Immunology ·Francesca Alessandrini, Renske de Jong, M Wimmer, (unknown), Isis E. Fernandez, (unknown), Jeroen Buters, Tilo Biedermann, Ulrich M. Zissler, Christian Hoffmann, Julia Esser‐von Bieren, Carsten B. Schmidt‐Weber, Caspar Ohnmacht	12
4	CX3CR1–fractalkine axis drives kinetic changes of monocytes in fibrotic interstitial lung diseases 2019 ·European Respiratory Journal ·Flavia R. Greiffo, (unknown), Marion Frankenberger, (unknown), Almudena Ortega‐Gómez, Joyce Lee, Anne Hilgendorff, Jürgen Behr, Oliver Soehnlein, Oliver Eickelberg, Isis E. Fernandez	17
5	Lung Adenocarcinoma Syndecan-2 Potentiates Cell Invasiveness 2018 ·American Journal of Respiratory Cell and Molecular Biology ·Konstantin Tsoyi, Juan C. Osorio, Sarah Chu, Isis E. Fernandez, Sergio Poli, Lynette M. Sholl, Ye Cui, Carmen S. Tellez, Jill M. Siegfried, Steven A. Belinsky, Mark A. Perrella, Souheil El‐Chemaly, Iván O. Rosas	19
6	Pharmacometabolic response to pirfenidone in pulmonary fibrosis detected by MALDI-FTICR-MSI 2018 ·European Respiratory Journal ·Na Sun, Isis E. Fernandez, (unknown), Michael Witting, Michaela Aichler, Annette Feuchtinger, Gerald Burgstaller, Stijn E. Verleden, Philippe Schmitt‐Kopplin, Oliver Eickelberg, Axel Walch	25
7	Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis 2016 ·European Respiratory Journal ·Isis E. Fernandez, Flavia R. Greiffo, Marion Frankenberger, (unknown), Katharina Heinzelmann, Claus Neurohr, Rudolf Hatz, Dominik Hartl, Jürgen Behr, Oliver Eickelberg	60
8	Glutathione peroxidase 3 localizes to the epithelial lining fluid and the extracellular matrix in interstitial lung disease 2016 ·Scientific Reports ·Andrea C. Schamberger, Herbert B. Schiller, Isis E. Fernandez, Martina Šterclová, Katharina Heinzelmann, Elisabeth Hennen, Rudolf Hatz, Jürgen Behr, Martina Vašáková, Matthias Mann, Oliver Eickelberg, Claudia A. Staab-Weijnitz	32
9	Exercise Reduces Lung Fibrosis Involving Serotonin/Akt Signaling 2016 ·Medicine & Science in Sports & Exercise ·(unknown), Manoel Carneiro Oliveira‐Junior, BreAnne MacKenzie, (unknown), (unknown), Flavia R. Greiffo, Nicole Cristine Rigonato‐Oliveira, (unknown), Humberto Dellê, Marco Idzko, Regiane Albertini, Ana Paula Ligeiro de Oliveira, Nilsa Regina Damaceno‐Rodrigues, Élia Garcia Caldini, Isis E. Fernandez, Hugo C. Castro‐Faria‐Neto, Marisa Dolhnikoff, Oliver Eickelberg, Rodolfo P. Vieira	28
10	Regulation of 26S Proteasome Activity in Pulmonary Fibrosis 2015 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), (unknown), Martina Korfei, (unknown), Isis E. Fernandez, Heiko Adler, Andreas Günther, Oliver Eickelberg, Silke Meiners	36
11	Characteristic Patterns in the Fibrotic Lung. Comparing Idiopathic Pulmonary Fibrosis with Chronic Lung Allograft Dysfunction 2015 ·Annals of the American Thoracic Society ·Isis E. Fernandez, Katharina Heinzelmann, Stijn E. Verleden, Oliver Eickelberg	16
12	Validation of the 2nd Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis 2015 ·PLoS ONE ·(unknown), (unknown), Isis E. Fernandez, Mélanie Königshoff, Oliver Eickelberg, Tobias Stöger, Silke Meiners	9
13	Resveratrol regulates ECM remodeling in lung fibrosis 2014 ·European Respiratory Journal ·Nikica Miše, Isis E. Fernandez, Oliver Eickelberg	5
14	Compartment-specific overexpression of glutathione peroxidases during lung fibrosis 2014 ·European Respiratory Journal ·Claudia A. Staab-Weijnitz, Isis E. Fernandez, Herbert B. Schiller, Katharina Heinzelmann, Martina Šterclová, Martina Vašáková, Matthias Mann, Oliver Eickelberg	1
15	Syndecan-2 Exerts Antifibrotic Effects by Promoting Caveolin-1–mediated Transforming Growth Factor-β Receptor I Internalization and Inhibiting Transforming Growth Factor-β1 Signaling 2013 ·American Journal of Respiratory and Critical Care Medicine ·Yuanyuan Shi, Bernadette R. Gochuico, Guoying Yu, (unknown), Juan C. Osorio, Isis E. Fernandez, (unknown), Avignat S. Patel, Ying Shi, Marc Wathelet, Andrew Goodwin, Jeffrey A. Haspel, Stefan W. Ryter, Eric M. Billings, Naftali Kaminski, Danielle Morse, Iván O. Rosas	45
16	Interstitial Lung Abnormalities and Reduced Exercise Capacity 2012 ·American Journal of Respiratory and Critical Care Medicine ·Tracy J. Doyle, George R. Washko, Isis E. Fernandez, Mizuki Nishino, Yuka Okajima, Tsuneo Yamashiro, Miguel Divo, Bartolomé R. Celli, Frank C. Sciurba, Edwin K. Silverman, Hiroto Hatabu, Iván O. Rosas, Gary M. Hunninghake	87
17	The Impact of TGF-β on Lung Fibrosis: From Targeting to Biomarkers breakdown → 2012 ·Proceedings of the American Thoracic Society ·Isis E. Fernandez, Oliver Eickelberg	549
18	Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities breakdown → 2011 ·New England Journal of Medicine ·George R. Washko, Gary M. Hunninghake, Isis E. Fernandez, Mizuki Nishino, Yuka Okajima, Tsuneo Yamashiro, James C. Ross, Raúl San Jośe Estépar, David A. Lynch, John M. Brehm, Katherine P. Andriole, Alejandro A. Díaz, Ramin Khorasani, (unknown), Frank C. Sciurba, Edwin K. Silverman, Hiroto Hatabu, Iván O. Rosas	384
19	Oncospheral peptide-based ELISAs as potential seroepidemiological tools for Taenia solium cysticercosis/neurocysticercosis in Venezuela 2005 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·Elizabeth Ferrer, (unknown), (unknown), (unknown), (unknown), (unknown), Hilda Pérez, Isis E. Fernandez, (unknown), Leslie J.S. Harrison, R. M. E. Parkhouse, Teresa Gárate	13
20	A hyperglycemic peptide hormone from the Caribbean shrimp Penaeus (litopenaeus) schmitti☆ 2000 ·Peptides ·Alberto Huberman, Manuel B. Aguilar, Iván Navarro-Quiroga, (unknown), Isis E. Fernandez, Forest M. White, Donald F. Hunt	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact